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Telomere Visualization in Tissue 
Sections using Pyrrole–Imidazole 
Polyamide Probes
Asuka Sasaki1, Satoru Ide1, Yusuke Kawamoto2, Toshikazu Bando2, Yukinori Murata3, 
Mari Shimura4, Kazuhiko Yamada5, Akiyoshi Hirata6, Kiyoshi Nokihara6, Tatsumi Hirata7, 
Hiroshi Sugiyama2 & Kazuhiro Maeshima1
Pyrrole–Imidazole (PI) polyamides bind to specific DNA sequences in the minor groove with high 
affinity. Specific DNA labeling by PI polyamides does not require DNA denaturation with harsh 
treatments of heat and formamide and has the advantages of rapid and less disruptive processing. 
Previously, we developed tandem hairpin PI polyamide probes (TH59 series), which label telomeres in 
cultured cell lines more efficiently than conventional methods, such as fluorescence in situ hybridization 
(FISH). Here, we demonstrate that a TH59 derivative, HPTH59-b, along with immunostaining 
for specifying cell types in the tissues, visualizes telomeres in mouse and human tissue sections. 
Quantitative measurements of telomere length with single-cell resolution suggested shorter telomeres 
in the proliferating cell fractions of tumor than in non-tumor tissues. Thus, PI polyamides are a 
promising alternative for telomere labeling in clinical research, as well as in cell biology.
Mammalian telomeres consist of a long array of repetitive sequence (TTAGGG) and cap chromosome ends to 
prevent chromosome instability. Without the telomerase activity that can elongate telomeres, telomere length 
shortens with every cell division. Upon reaching a critical short length, the telomeres can trigger senescence, 
which suppresses the abnormal growth associated with tumorigenesis1–3. Telomerase reactivation can induce cells 
to circumvent growth limitation by telomere-dependent senescence and lead to immortalization4,5. Induction 
of the recombination between telomeres, termed alternative lengthening of telomeres (ALT), can also lead to a 
similar effect on the cells6,7.
Telomere length can be used as a diagnostic marker to detect immortalized cells with short telomeres or ALT 
cells with much longer telomeres. Thus far, quantitative fluorescent in situ hybridization (Q-FISH) with a pep-
tide nucleic acid (PNA) probe has been widely used to visualize relative telomere length in individual cells8–10. 
Many clinical studies of telomere length measurement by Q-FISH have demonstrated that some types of cancer 
cells have shortened telomeres11–13. However, the FISH method requires harsh treatment using heat and 50% 
formamide for probe hybridization, which carries the risk of destroying cellular structures. Indeed, only a few 
studies have performed telomere labeling along with immunostaining for a cell marker (e.g., tumor marker) 
that can provide results with physiological relevance in human tissue sections14. Additionally, simple and less 
time-consuming steps and labeling reproducibility, such as clinical studies with numerous samples, are preferable 
for high-throughput experiments. The ‘gold standard’ for labeling telomeres, FISH, still has issues to be resolved, 
including for instance, the time required and convenience.
N-methylpyrrole (P)− N-methylimidazole (I) (PI) polyamides bind to the minor groove of duplex DNA with-
out denaturation and can recognize Watson–Crick base pairs (Fig. 1A)15–22. PI polyamide is an alternative to 
1Structural Biology Center, National Institute of Genetics, and Department of Genetics, Sokendai (Graduate 
University for Advanced Studies), Mishima, Shizuoka 411-8540, Japan. 2Department of Chemistry, Graduate School 
of Science, Kyoto University, Sakyo, Kyoto 606-8502, Japan. 3Department of Pathology, Hospital, National Center 
for Global Health and Medicine, Shinjuku, Tokyo 162-8655, Japan. 4Department of Intractable Diseases, Research 
Institute, National Center for Global Health and Medicine, Shinjuku, Tokyo 162-8655, Japan. 5Department of Surgery, 
Hospital, National Center for Global Health and Medicine, Shinjuku, Tokyo 162-8655, Japan. 6HiPep Laboratories, 
Nakatsukasa-cho 486-46, Kamigyo-ku, Kyoto 602-8158, Japan. 7Division of Brain Function, Department of Integrated 
Genetics, National Institute of Genetics, and Department of Genetics, Sokendai, Mishima, Shizuoka 411-8540, 
Japan. Correspondence and requests for materials should be addressed to S.I. (email: satide@nig.ac.jp) or 
K.M. (email: kmaeshim@nig.ac.jp)
Received: 12 May 2016
accepted: 13 June 2016
Published: 06 July 2016
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 6:29261 | DOI: 10.1038/srep29261
the nucleic acid probes, which require a hybridization step to denature target DNA, for labeling specific DNA 
sites of the genome. Maeshima et al. reported on fluorescent tandem hairpin PI polyamide (TH59) probes that 
target human telomere sequences (TTAGGG)n under mild conditions23. A hairpin structure is composed of two 
antiparallel linear compounds folded as a U-shape and is connected to another hairpin moiety through a hinge 
segment (Fig. 1B). Previously, to increase the binding selectivity of TH59, we developed a method for the robust 
synthesis of TH59 and various derivatives of TH59 with higher specificity for human telomeres in the cell24–26.
Here, we show that HPTH59-b, which has a hinge with an optimal length between two hairpins, visualizes 
telomeres not only in cultured cells but also in mouse and human frozen tissue sections (Fig. 1C). The tissue sec-
tions were co-stained with HPTH59-b and antibodies for cell-specific markers to compare the telomere lengths 
in various cell populations in the tissue sections. By quantitatively measuring telomeres in clinical tissue from an 
esophageal cancer patient, we found that a cell population positive for a proliferation marker, Ki-67 protein, has 
shorter telomeres than do the Ki-67-negative cells in non-tumor tissue sections. Therefore, PI polyamide provides 
an advantageous alternative for the measurement of telomere length in clinical research.
Figure 1. Structure of fluorescent polyamide HPTH59-b and scheme for telomere labeling.  
(A) A structural model of HPTH59-b binding to DNA. (B) Chemical structure of HPTH59-b. TAMRA  
is tetramethylrhodamine. In the box, the base recognition profile of HPTH59-b is shown. (C) A simple  
scheme for telomere labeling using HPTH59-b. Green dots indicate signals from telomere repeats.
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Results
Telomere length measurement by quantitative PI polyamide labeling. Several studies have 
shown that telomeres in cancer tissues are often shorter than those in normal tissues27–29; thus, quantitative tel-
omere measurement should make an important contribution to investigations of tumorigenesis. To verify the 
quantification of telomere length by PI polyamide labeling, we stained the telomeres in cells having different 
lengths of telomere repeats with fluorescently labeled HPTH59-b25 and 4′ , 6-diamidino-2-phenylindole (DAPI) 
(Fig. 2A,B). The telomere lengths of HeLaS3, HeLa1.3, and U2-OS ALT cells are 2–10 kb, ~23 kb, and < 3 to 
>50 kb, respectively30,31.
As shown in Fig. 2A, HeLa1.3 cells exhibited more intense HPTH59-b signals than did HeLaS3 cells. Quantitative 
measurement of their signal intensities normalized to the DAPI signal indicated that the telomere signals of 
HeLa1.3 cells were significantly higher than those of HeLaS3 (Fig. 2B). Moreover, quantitative measurement of 
telomere signals on chromosomal spreads also showed that the signals at every chromosomal end of HeLa1.3 cells 
were higher than those of HeLaS3 cells (Supplementary Fig. S1A,B), suggesting that the telomeres of HeLa1.3 are 
longer than those of HeLaS3 cells. In U2-OS cells, we observed the strongest telomere signals among three cell 
lines (Fig. 2A). Additionally, U2-OS cells had several intense signals even outside the nucleus, which have been 
reported to be extra-chromosomal telomere DNA in the cytoplasm32. These results suggested that the observed 
signal intensity of HPTH59-b can distinguish different telomere lengths among these cultured cells.
Telomere labeling in tissue sections. Next, to examine whether the telomere labeling by HPTH59-b 
can be applied to cells in tissues, we prepared frozen tissue sections of a mouse (20-μ m thickness) and 
stained them with fluorescent HPTH59-b (green). Images of lung and brain regions are presented in Fig. 3A. 
Intense HPTH59-b foci in the DAPI-staining DNA region were clearly detected in both tissues. To test the 
telomere-targeting efficiency of HPTH59-b, we stained mouse tissue sections with HPTH59-b and anti-TRF1 
(telomere-binding protein) antibody simultaneously and compared the signals. We observed strong signals of 
HPTH59-b with low background noise, whereas TRF1 signals were weak with high background noise in the brain 
and lung (Supplementary Fig. S2). Additionally, substantially more signals were detected by HPTH59-b than by 
TRF1 (Supplementary Fig. S2). On the other hand, in cultured murine cells (MC12), the intensity and number 
of HPTH59-b signals were comparable to those of TRF1signals (Supplementary Fig. S2). Thus, the HPTH59-b 
probe might label telomeres in tissue sections more efficiently than immunostaining.
In telomere biology, information on telomere length in a certain cell population in tissues, especially at the 
single-cell level, is very useful. To explore telomere length in a certain cell type, we focused on telomere length in 
a germ cell line, which has high telomerase activity. DEAD box proteins (DDX), putative RNA helicases, are spe-
cifically and highly expressed in the germ cell lineage in both sexes, and they are widely used as a marker of germ 
cell lineage33,34. Testis sections containing gonadal tissues, where primordial germ cells (PGCs) are located, were 
treated with HPTH59-b (red) and anti-DDX4/MVH antibody (green). Immunostaining with anti-DDX4/MVH 
antibody specifically labeled the cytosol of PGCs, and HPTH59-b showed clear foci in both the germ cells and 
somatic cells (Fig. 3B). The telomere signals in PGCs seemed to be weaker than those in PGC marker-negative 
cells. The PGC marker-positive cells showed a unique characteristic of nuclear organization: less DAPI staining 
over the nucleus, which is consistent with a previous report35. The quantitative measurement of telomere signals 
normalized to the DAPI signal suggested that PGCs had slightly longer telomeres than the PGC-negative cells 
(Supplementary Fig. S3). These results demonstrated that HPTH59-b highlighted telomeres and the antibody 
marked PGCs simultaneously, thereby demonstrating that double staining with HPTH59-b and antibodies can 
be used to label telomeres in a specific cell lineage in tissue.
Shorter telomeres in human tumor cells. Telomere length is strongly connected to cell immortalization 
and tumorigenesis. Indeed, telomere shortening has been observed in carcinoma from bladder, esophageal, gas-
tric, head and neck, ovarian, and renal cells36,37. To further investigate telomeres in human neoplastic lesions, we 
performed simultaneous labeling in esophageal cancer tissue using HPTH59-b and an antibody for a proliferation 
marker, Ki-67 protein. Ki-67 is highly expressed in cells that are actively dividing, but it is absent in cells under a 
quiescent state, such as the G0 phase of the cell cycle38. We found that some cell fractions in the lesions were still 
Ki-67-positive (green) and the fluorescent intensity of telomere foci appeared lower than that of Ki-67-negative 
cells (Fig. 4A). Using digital image analysis, we quantitatively compared telomere lengths (Fig. 4B). The distribu-
tion map of the telomere signals revealed two distinct peaks between tumor and non-tumor tissues. These results 
suggest that highly proliferating tumor cells have shorter telomeres than normal cells, and HPTH59-b can detect 
differences in telomere length between tumor and non-tumor cells in tissues.
Discussion
To demonstrate and verify the application of PI polyamide to clinical studies, we used PI polyamide HPTH59-b, 
along with immunostaining, to visualize telomeres in mouse and human frozen tissue sections. Our quantitative 
analysis of the telomere signals also suggested that highly proliferating cells in tumor tissue had shorter telomeres 
than normal cells in non-tumor tissue. Although the issue of whether telomere shortening is a consequence of cell 
proliferation during tumor expansion or a cause of tumorigenesis initiation is controversial, HPTH59-b provides 
a simple and quick detection method for telomere alteration of the cancer genome at the single-cell level, thereby 
contributing to the genetic diagnosis of malignancy and drug response in patients.
Telomere visualization by HPTH59-b has several advantages over the Q-FISH method. First, the sample 
preparation process is much faster. Even with tissue sections, incubation with HPTH59-b for just 1 hour is suffi-
cient for staining telomeres. Moreover, even when co-staining with HPTH59-b and an antibody for cell-specific 
markers, the whole procedure can be completed within 4.5 h. The second advantage is high sensitivity. As shown 
in Supplementary Fig. S2, HPTH59-b generated more telomere signals with lower background noise than did 
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immunostaining with a TRF1 antibody, whereas with cultured cells, HPTH59-b showed a staining efficiency 
comparable to that of a TRF1 antibody. In the case of thicker tissue sections, the probe size might be critical to 
accessing telomeres, and HPTH59-b (2.67 kDa) is much smaller than antibodies (~150 kDa). The third advan-
tage is that HPTH59-b labeling can be carried out under mild conditions. This probe can also detect telomere 
sequences in small DNA molecules in the cytoplasm of ALT cells, which have extra-chromosomal circular DNA 
of telomeric repeats due to the high activity of recombination39,40. Only a few studies using the conventional FISH 
method have ever reported the extra-chromosomal DNA in cytoplasm32. This is probably because, unlike large 
Figure 2. Quantitative telomere labeling using HPTH59-b. (A) Telomere labeling with HPTH59-b in human 
cultured cells. Telomerase-active cells (HeLa1.3 and HeLaS3) and alternative lengthening of telomere (ALT) 
cells (U2-OS) were stained with DAPI (first column) and HPTH59-b (second column). Merged images are in 
the third column. The fourth column shows merged images of HPTH59-b staining and differential interference 
contrast (DIC) images. Note that some U2-OS cells have extra-nuclear telomere signals (yellow arrowhead). 
(B) Distribution histograms of telomere signal intensities in HeLa1.3 (long telomere; in blue) and HeLaS3 
(short telomere; in red) cells. The overlapping area of the two distributions is shown in purple. The numbers of 
telomere signals measured for HeLa1.3 and HeLaS3 cells are 13171 dots from 280 cells and 10805 dots from 277 
cells, respectively. Median values of the intensity distributions for HeLa1.3 and HeLaS3 are 50.0 (blue arrow) 
and 26.7 (red arrow), respectively. To compare these median values, the Wilcoxon rank sum test was used 
(P < 0.01).
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Figure 3. Telomere labeling in frozen mouse tissue sections. (A) First column, DAPI signal; second column, 
HPTH59-b signal; third column, merged images of DAPI and HPTH59-b. Enlarged images of the boxed region 
in the upper part are shown in the lower part. (B) Neonatal (P0) mouse gonads stained with DAPI (blue), anti 
DDX4/MVH antibody (germ cell marker; green), and HPTH59-b (red). Enlarged images of the boxed region in 
the first-row images are shown in the second row.
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Figure 4. Different telomere lengths between human tumor and non-tumor tissue sections. (A) Frozen 
sections of esophageal tumor/non-tumor tissue stained with DAPI (blue), anti-Ki-67 (growth marker; green) 
antibody, and HPTH59-b (red). Enlarged images of the boxed region in the upper images are shown in the 
lower part. (B) Distribution histograms of telomere signal intensities in tumor (shown in red; 511 dots from  
54 cells) and non-tumor (in blue; 635 dots from 50 cells) tissue sections. Median values of the signal intensities 
in non-tumor and tumor tissues are 27.8 (blue arrow) and 16.7 (red arrow), respectively. The overlapping area of 
the two distributions is shown in purple. To compare these median values, the Wilcoxon rank sum test was used 
(P < 0.01).
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genomic DNA, such small circular plasmid-like DNAs may be easily washed away during the harsh hybridization 
process and/or easily re-annealed, preventing the nucleic acid probes from hybridization. In contrast, HPTH59-b 
binds to dsDNA TTAGGG repeats without denaturation, and it may have a similar labeling efficiency for the 
extra-chromosomal and chromosomal telomere repeats.
Two new telomere labeling methods that use genome editing systems have recently been established. One 
involves telomere labeling using a transcription activator-like effector (TALE)-based strategy in both fixed and 
living mammalian cells41,42. Although the TALE-based method is applicable to live-cell imaging, it is time con-
suming (i.e., for plasmid construction and establishment of stable cell lines expressing the fluorescent-TALE). 
Moreover, the TALE-based strategy cannot be applied to telomere labeling in tissue sections, especially clinical 
samples from patients. On the other hand, HPTH59-b can label telomeres in both cultured cells and tissue sec-
tions without have to construct plasmids or establish stable cell lines.
Another recent approach uses the clustered regularly interspaced short palindromic repeats (CRISPR)/
CRISPR-associated caspase 9 (Cas9) technique43. Recently, Deng et al. reported the use of in vitro constituted 
nuclease-deficient CRISPR/Cas9 complexes as probes (Cas9-mediated fluorescence in situ hybridization, 
CASFISH)44. Telomere labeling by this method does not require DNA denaturation and can quickly (15 min) 
label telomeres in cultured cells and tissue sections. On the other hand, the production cost of large amounts 
of single-guide RNAs (sgRNAs) and dCas9 (nuclease-deficient) protein make it more expensive than the 
HPTH59-b method, which could be problematic for high-throughput applications, such as those involved in 
cancer diagnosis.
With the recent development of new technologies, our understanding of chromatin structure and dynam-
ics is deepening45. Because our sensitive telomere labeling method can be performed under mild conditions, 
another interesting application to telomere regions involves super-resolution imaging without harsh treatments. 
This technique could help to elucidate how telomere chromatin is organized in the cell nuclei. Therefore, telomere 
visualization using the PI polyamide-based approach discussed here would expand telomere biology and related 
medical science.
Methods
Synthesis. HPTH59-b was synthesized as reported previously25.
Human tissues. The use of human tissues was approved by the committees of the National Center for Global 
Health and Medicine (#NCGM-G-001766-00) and was in accordance with the Declaration of Helsinki of the 
World Medical Association. Participants provided written informed consent. We analyzed one case of a patient 
who had a surgical operation at the National Center for Global Health and Medicine Hospital. Tissues were pre-
pared from regions diagnosed as esophageal squamous cell carcinoma and adjacent normal tissue according to 
the manufacturer’s protocol. Briefly, excised tissue was flash frozen in cold acetone with optimal cutting temper-
ature (OCT) compound (Sakura Finetek Japan). Tissue sections (10 μ m) were prepared by microtome and placed 
on the slide glass for telomere staining.
Telomere staining of HeLaS3, HeLa1.3, and U2-OS cells with HPTH59-b. HeLa cells were 
maintained at 37 °C under 5% CO2 atmosphere in DMEM containing 10% fetal bovine serum (FBS). For pol-
yamide staining, cells were grown on coverslips coated with poly-lysine. The cell coverslips were washed in 
phosphate-buffered saline (PBS) twice and fixed with 1.85% formaldehyde in PBS. The fixed cells on coverslips 
were stained with HPTH59-b and then mounted as described previously24. Section images were recorded with 
a DeltaVision microscope and deconvolved to eliminate out-of-focus blur to obtain clearer pictures. The decon-
volved images were projected (‘Quick Projection’ tool) to obtain the maximum intensity of telomere signals. 
Non-deconvolved pictures were used for quantitative analysis of HPTH59-b signals.
Telomere staining of mouse tissue sections with HPTH59-b. Postnatal 0 (P0) mice were fixed in 
4% paraformaldehyde in PBS overnight at 4 °C and placed in 30% sucrose in PBS for 1 day at 4 °C. Mouse whole 
bodies were then embedded in optimal cutting temperature (OCT) compound /30% sucrose (2:1) and incubated 
for 1 h at room temperature. Embedded samples were stored at − 80 °C until sectioning. Samples were sectioned 
(20 μ m) using a CM3050S cryostat (Leica) and kept at − 30 °C until use. All experimental protocols were approved 
by the Animal Committee of the National Institute of Genetics and carried out according to the guidelines to 
minimize the pain and discomfort of the animals.
Preparation of human tumor/non-tumor tissue sections. Before staining, sections were incubated in 
HEN buffer (10 mM HEPES pH 7.5, 1 mM EDTA, 100 mM NaCl) overnight at 37 °C. The sections were perme-
abilized with 0.1% Triton X-100 for 10 min and briefly washed twice with TEN (10 mM Tris-HCl pH 7.5, 1 mM 
EDTA, 100 mM NaCl). For blocking, the sections were treated with Normal Goat Serum (NGS) in TE buffer 
(10 mM Tris-HCl pH 7.5, 1 mM EDTA) for 30 min at room temperature. After a brief rinse with TE buffer, the 
sections were incubated with 10% NGS, 15 nM HPTH59-b, and 0.5 μ g/mL DAPI for 2 h at 37 °C. After washing 
five times for 3 min with TEN200 buffer (10 mM Tris-HCl pH 7.5, 1 mM EDTA, and 200 mM NaCl), the sections 
were mounted and image acquisition was performed as described above.
Co-staining with polyamide and antibody. The procedure from sample preparation to blocking was 
the same as that described above. The sections were incubated with 10% NGS, 15 nM HPTH59-b, 0.5 μ g/mL 
DAPI, and either anti-DDX4/MVH antibody (Abcam #ab13840, 1:500 dilution) or anti-Ki-67 antibody (Oncogene 
#NA59, 1:20 dilution) for 2 h at 37 °C46, following the process from washing to image acquisition as described above.
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Quantification of telomere signals. Images of HeLa1.3 and HeLaS3 cells and human/mouse tissue sec-
tions were recorded with a DeltaVision microscope under identical conditions. Non-deconvolved images were 
projected and used as source images. Extraction of each telomere signal was performed as follows. The back-
ground fluorescent signals of HPTH59-b and DAPI in the source images were subtracted using the ‘Rolling 
ball’ tool (Fiji)47. By setting an arbitrary threshold value of HPTH59-b intensity, the telomere spots were con-
toured. The maximal signal intensities of HPTH59-b and DAPI were extracted from each telomere spot, and each 
HPTH59-b signal was then normalized with DAPI signals. The Wilcoxon rank sum test was used for statistical 
analysis, which was performed with R software48.
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